Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Copper therapy of inflammatory disorders in man: special reference to rheumatoid arthritis

  • Chapter
Copper and Zinc in Inflammation

Part of the book series: Inflammation and Drug Therapy Series ((IDTH,volume 4))

Abstract

There is a resurgence of interest in the essential metals, particularly copper and zinc, in the treatment of the rheumatic diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Neuberger, M (1910). History of Medicine. (London: Bedford Medical Publications)

    Google Scholar 

  2. Walker, WR and Keats, DM (1976). An investigation of the therapeutic value of the copper bracelet. Dermal assimilation of copper in arthritic/rheumatoid conditions. Agents Actions, 6, 454–9

    Article  PubMed  CAS  Google Scholar 

  3. Walker, WR (1982). The results of a copper bracelet clinical trial and subsequent studies. In: Sorenson, JRJ (ed), Inflammatory Diseases and Copper, (Clifton, NJ: Huana Press) pp. 469–78

    Google Scholar 

  4. Simkin, P. In: Sorenson, JRJ (ed), Inflammatory Diseases and Copper, (Clifton, NJ: Humana Press), pp.

    Google Scholar 

  5. Dollwet, HH, Schmidt, SP and Seaman, RE (1981). Antiinflammatory properties of copper implants in the rat paw edema: a preliminary study. Agents Actions, 11(6/7), 746–9

    Article  PubMed  CAS  Google Scholar 

  6. Goralewski, G (1940). Das Kupfer in der Behandlung der lungentuberkulose. Z Tuberk, 84, 313–19

    Google Scholar 

  7. Fenz, E (1941). Kupfer ein neues Mittel gegen chronischen und subacuten Gelenkrheumatismus. Münch Med Wochenchschr, 88, 1101–5

    Google Scholar 

  8. Lande, K (1927). Die günstige Beeinflussung schleichender Dauerinfecte durch Sol-ganal. Münch Med Wochenschr, 74, 1132–4

    Google Scholar 

  9. Forestier, JM (1929). L’aurothérapie dans les Rhumatismes Chroniques. Bull Mem Soc Med Hop Paris, 53, 323–7

    Google Scholar 

  10. Forestier, J (1946). Indications et technique des composés organo-metalliques de cuivre dans le Rhumatisme chronique. Bull Acad Med Paris, 130, 298–9

    CAS  Google Scholar 

  11. Forestier, JM and Certonciny, A (1946). Le Treatment des rhumatismes chroniques par les sels organiques de cuivre. Presse Med, 54, 884–5

    Google Scholar 

  12. Forestier, JM, Jacqueline, F and Lenoir, S (1948). La Cuprothérapie intramusculaire dans les rhumatismes chroniques inflammatoires. Presse Med, 56, 351–2

    Google Scholar 

  13. Forestier, JM (1949). Comparative results of copper salts and gold salts in rheumatoid arthritis. Ann Rheum Dis, 8, 132–4

    Article  PubMed  CAS  Google Scholar 

  14. Forestier, JM and Certonciny, A (1949). La goutte polyarticulaire chronique et son traitment par les metaux lourds. Bull Acad Med, 133, 243

    CAS  Google Scholar 

  15. Forestier, JM, Certonciny, A and Jacqueline, F (1950). Therapeutic value of copper salts in rheumatoid arthritis. Stanford Med Bull, 8, 12–13

    Google Scholar 

  16. Kuzell, WC, Schaffarzick, RW, Markle, EA and Gardner, GM (1951). Copper treatment of experimental and clinical arthritis. Ann Rheum Dis, 10, 328–36

    Article  PubMed  CAS  Google Scholar 

  17. Short, CL and Bauer, W (1948). Course of rheumatoid arthritis in patients receiving simple medical and orthopaedic measures. N Engl J Med, 238, 142–8

    Article  PubMed  CAS  Google Scholar 

  18. Hangarter, W and Lubke, A (1952). Über die behandlung rheumatischer erkrankungen mit einer kuper natrium salicylate-complex Verbindung. Permalon. Dtsch Wochenschr, 77, 870–2

    Article  CAS  Google Scholar 

  19. Hangarter, W (1974). Die salicylsaure und ihre Abkommlinge-Ursprung Wirkung und Anwendung in der Medizine. (New York; FK Schattauer Verlag), pp. 312–15

    Google Scholar 

  20. Sorenson, JR and Hangarter, W (1977). Treatment of rheumatoid and degenerative diseases with copper complexes: a review with emphasis on copper-salicylate. Inflammation, 2 217–38

    Article  PubMed  CAS  Google Scholar 

  21. Underwood, EJ (1977). Trace Elements in Human and Animal Nutrition, 4th edn. (New York: Academic Press), pp. 56–108

    Google Scholar 

  22. Sorenson, JRJ (1978). An evaluation of altered copper, iron, magnesium, manganese and zinc concentrations in rheumatoid arthritis. Inorg Perspect Biol Med, 2, 1–26

    CAS  Google Scholar 

  23. Krebs, HA (1928). Über das Kupfer in menschlichen blutserum. Klin Wochenschr, 7, 584–5

    Article  CAS  Google Scholar 

  24. Thomson, RHS and Watson, D (1949). Serum copper levels in pregnancy and preeclampsia. J Clin Pathol, 2,193–6

    Article  Google Scholar 

  25. Lahey, ME, Gobler, CJ, Cartwright, GE and Wintrobe, MM (1953). Studies on copper metabolism — VII Blood copper in pregnancy and various pathological states. J Clin Invest, 32, 329–39

    Article  PubMed  CAS  Google Scholar 

  26. Persellin, RH (1976). The effects of pregnancy on rheumatoid arthritis. Bull Rheum Dis, 27 , 922–1

    PubMed  Google Scholar 

  27. Froelich, CJ, Goodwin, JS, Banhurst, A and Williams, RC (1980). Pregnancy: a temporal fetal graft of suppressor cells in autoimmune disease. Am J Med, 69, 329–31

    PubMed  CAS  Google Scholar 

  28. Denko, CW (1979). Protective role of ceruloplasmin in inflammation. Agente and Actions, 9, 333–6

    Article  CAS  Google Scholar 

  29. Russ, EM and Raymunt, J (1956). Influence of estrogens in total serum copper and ceruloplasmin. Proc Soc Exp Biol Med, 92, 466–6

    Google Scholar 

  30. Crews, MG, Taper, LJ and Ritchey, S J (1980). Effects of oral contraceptive agents on copper and zinc balance in young women. Am J Clin Nutr, 33, 1940–5

    PubMed  CAS  Google Scholar 

  31. Royal College of General Practitioners (1974). Oral Contraceptive Study: oral contraceptives and health. (London: Pitman Medical Publishing)

    Google Scholar 

  32. Van Ravesteijn, S (1945). Over de Koperstofwisseling by den mensch en over het kopergehalte van het blet by normale en zieke personen. MD Thesis. Utrecht. P Den Boer

    Google Scholar 

  33. Milanino, R, Conforti, A, Franco, L et al. (1985). Review: Copper and inflammation — a possible rationale for the pharmacological manipulation of inflammatory disorders. Agents and Actions, 16, 504–13

    Article  PubMed  CAS  Google Scholar 

  34. Milanino, R and Velo, GP (1981). Multiple actions of copper in control of inflammation: studies in copper-deficient rats. In: Rainsford, KD, Brune, K and White-house, MW (eds), Trace Elements in the Pathogenesis and Treatment of Inflammation. (Basel: Birkhauser Verlag), pp. 209–30

    Google Scholar 

  35. Niedermeier, W (1969). Concentration and clinical state of copper in synovial fluid and blood serum of patients with rheumatoid arthritis. Ann Rheum Dis, 24, 544–8.

    Article  Google Scholar 

  36. Grennan, DM, Knudson, JM, Dunckley, J et al. (1980). Serum copper and zinc in rheumatoid arthritis and osteoarthritis. NZ Med J, 91, 47–50

    CAS  Google Scholar 

  37. Plantim, IO and Strandberg, PO (1965). Whole-blood concentrations of copper and zinc in rheumatoid arthritis studied by activation analysis. Acta Rheum Scand, 11, 30–4

    Google Scholar 

  38. Lorber, A, Cutler, LS and Chang, CC (1968). Serum copper levels in rheumatoid arthritis: relationship of elevated copper to protein alterations. Arthr Rheum, 11, 65–71

    Article  CAS  Google Scholar 

  39. Sorenson, JRJ and DiTommaso, D (1976). Significance of plasma copper and caeru-loplasmin concentrations in rheumatoid arthritis. Ann Rheum Dis, 35, 186–8

    Article  PubMed  CAS  Google Scholar 

  40. Scudder, PR, Al-Timini, D, McMurray, W et al. (1978). Serum copper and related variables in rheumatoid arthritis. Ann Rheum Dis, 37, 67–70

    Article  PubMed  CAS  Google Scholar 

  41. Niedermeier, W, Creitz, EE and Holley, HL (1962). Trace metal composition of synovial fluid from patients with rheumatoid arthritis. Arth Rheum, 5, 439–444

    Article  CAS  Google Scholar 

  42. Niedermeier, W, Prillman, WM and Griggs, JH (1971). The effect of chrysotherapy on trace elements in patients with rheumatoid arthritis. Arth Rheum, 14, 533–8

    Article  CAS  Google Scholar 

  43. Conforti, A, Franco, L, Milanino, R et al. (1982). Copper and ceruloplasmin activity in rheumatoid arthritis. In: Gorkin, S, Ziff, M, Velo, GP and Gorini, S (eds), Advances in Inflammation Research, Vol.3: Rheumatoid Arthritis. (New York: Raven Press), pp. 237–44

    Google Scholar 

  44. Koj, A (1970). Acute-phase reactants and lysosomal enzymes in the blood of rats with experimental inflammation or radiation injury. Fol Biol, 18, 274–86

    Google Scholar 

  45. Wintrobe, MM, Cartwright, GE and Gubler, CJ (1953). Studies on the function and metabolism of copper. J Nutr, 50, 395–419

    PubMed  CAS  Google Scholar 

  46. Milanino, R, Mazzoli, S, Passarella, E et al. (1978). Carrageenan edema in copper-deficient rats. Agents Actions, 8, 618–22

    Article  PubMed  CAS  Google Scholar 

  47. Milanino, R, Conforti, A, Fracasso, ME et al. (1979). Concerning the role of endogenous copper in the acute inflammatory process. Agent and Actions, 9, 581–8

    Article  CAS  Google Scholar 

  48. Laroche, M J, Chappuis, P, Henry, Y and Rousselet, F (1982). Ceruloplasmin. Experimental anti-inflammatory activity and physicochemical properties. In: Sorenson, JBL (ed), Inflammatory Diseases and Copper. (Clifton, NJ: Humana Press), pp. 61–74

    Google Scholar 

  49. Bajpayee, DP (1975). Significance of plasma copper and ceruloplasmin concentrations in rheumatoid arthritis. Ann Rheum Dis, 34, 162–7

    Article  PubMed  CAS  Google Scholar 

  50. Milanino, R, Passarella, E and Velo, GP (1979). Copper and the inflammatory process. In: Weismann, G et al. (eds), Advances in Inflammatory Research, Vol.1. (New York: Raven Press), pp. 281–91

    Google Scholar 

  51. Sorenson, JRJ (1977). Evaluation of copper complexes as potential antiarthritic drugs. J Pharm Pharmacol, 29, 450–2

    Article  PubMed  CAS  Google Scholar 

  52. Sorenson, JRJ (1976). Copper chelates as possible active forms of the antiarthritic agents. J Med Chem, 19, 135–48

    Article  PubMed  CAS  Google Scholar 

  53. Bonta, I, Parnham, MJ, Vincent, JE and Bragt, PC (1980). In: Ellis, PG and West GB (eds), Progress in Medicine and Chemistry. (Amsterdam: Elsevier/North Holland), vol.17, pp. 185–273

    Google Scholar 

  54. Sorenson, JRJ (1981). In: Rainsford, KD et al. (eds), Trace Elements in the Pathogenesis and Treatment of Inflammation. (Basel: Basel Birkhauser Verlag), p.305

    Google Scholar 

  55. Salin, ML and McCord, JM (1975). Free radicals and inflammation. Protection of phagocytosing leukocytes by superoxide dismutase. J Clin Invest, 56, 1319–23

    Article  PubMed  CAS  Google Scholar 

  56. McCord, JM and Fridovich, I (1968). The reduction of cytochrome c by milk xantine oxidase. J Biol Chem, 243, 5753–60

    PubMed  CAS  Google Scholar 

  57. McCord, JM (1974). Free radicals and inflammation. Protection of synovial fluid by superoxide dismutase (SOD). Science, 185, 529–31

    Article  PubMed  CAS  Google Scholar 

  58. Lunec, J, Halloran, SP, White, AG and Dormandy, TL (1981). Free radical oxidation (peroxidation) products in serum and synovial fluid in rheumatoid arthritis. J Rheumatol, 8, 233–45

    PubMed  CAS  Google Scholar 

  59. Fridovich, I (1975). Superoxide dismutase. Ann Rev Biochem, 44, 147–59

    Article  PubMed  CAS  Google Scholar 

  60. McCord, JM and Fridovich, I (1969). Superoxide dismutase: an enzymic function for erythrocuprein (hemocuprein). J Biol Chem, 244, 6049–55

    PubMed  CAS  Google Scholar 

  61. Huber, W, Schulte, TL, Carson, S et al. (1968). Some chemical and pharmacological properties of a novel anti-inflammatory protein. Toxicol Appl Pharmacol, 12, 308

    Google Scholar 

  62. Rister, M, Bauermeister, K, Gravert, V and Gladtke, E (1978). Superoxide dismutase deficiency in rheumatoid arthritis. Lancet, 1(8073), 1094

    Article  PubMed  CAS  Google Scholar 

  63. Pasquier, C, Laoussadi, S, Serfati, G et al (1985). Superoxide dismutases in polymorphonuclear leukocytes from patients with ankylosing spondylitis or rheumatoid arthritis. Clin Exp Rheum, 3, 123–6

    CAS  Google Scholar 

  64. Banford, JC, Brown, DH, Hazelton, RA et al (1982). Serum copper and erythrocyte superoxide dismutase in rheumatoid arthritis. Ann Rheum Dis, 41, 458–62

    Article  PubMed  CAS  Google Scholar 

  65. Lund-Olespm, K and Menander, KB (1974). Orgotein: A new anti-inflammatory me-talloprotein drug: Preliminary evaluation of clinical efficacy and safety in degenerative joint disease. Curr Therap Res, 16, 706–17

    Google Scholar 

  66. Puhl, W, Biehl, G, Kelgel, R and Hefer, M (1981). Eur J Rheumatol Inflamm, 4, 264

    PubMed  CAS  Google Scholar 

  67. Huskisson, EC and Scott, J (1981). Orgotein in osteoarthritis of the knee joint. Eur J Rheumatol Inflamm, 4, 212–8

    PubMed  CAS  Google Scholar 

  68. Wolf, B (1982). Therapy of inflammatory diseases with superoxide dismutase. In: Sorenson, JRJ (ed),Inflammatory Diseases and Copper. (Clifton, NJ: Humana Press), pp. 453–670

    Google Scholar 

  69. Huber, W, Menander-Huber, KB, Saifer, MGP and Dang, PHC (1977). Studies on the clinical and laboratory pharmacology of drug formulations of bovine Cu-Zn superoxide dismutase (Orgotein). In: Willoughby, DA et al. (eds), Perspectives in Inflammation. (Lancaster: MTP Press), pp. 527–44

    Google Scholar 

  70. Carson, S, Vagin, EE, Huber, W and Schulte, TL (1973). Safety tests of orgotein, an anti-inflammatory protein. Toxicol Appl Pharmacol, 26, 184–202

    Article  PubMed  CAS  Google Scholar 

  71. Bonta, IL, Bragt, PC and Muus, P (1982). Hepatic adaptation process during inflammatory conditions. Role of trace elements, lipid peroxidation and ceruloplasmin. In: Sorenson, JRJ (ed),Inflammatory Diseases and Copper. (Clifton, NJ: Humana Press), pp. 243–53

    Google Scholar 

  72. Fridovich, I, McCord, JM and Michelson, AM (1977). Epilogue and prospects. In: Michelson, AM et al. (eds), Superoxide and Superoxide Dismutase. (New York: Academic Press), pp. 551–6

    Google Scholar 

  73. Kuehl, FA, Jr, Humes, JL, Egan, RW et al. (1977). Role of prostaglandin endoper-oxide PGG2 in inflammatory processes. Nature, 256, 170–3

    Article  Google Scholar 

  74. Biork, J, Del Maestro, RF and Arfos, KE (1980). Evidence for participation of hydroxyl free radicals in increase microvascular permeability. In: Velo, GP (ed), Trends in Inflammation Research, Vol.1. (Basel: Birkhauser Verlag), pp. 208–13

    Google Scholar 

  75. McCord, JM, Stokes, SM and Wong, K (1979). Superoxide radicals as a phagocyte-producer chemical mediator of inflammation. In: Weissman, G (ed), Advances in Inflammation Research, Vol.1. (New York: Raven Press), pp. 273–80

    Google Scholar 

  76. Oyanagui, Y (1976). Participation of superoxide anions in the prostaglandin phase of carrageenan foot-oedema. Biochem Pharmacol, 25, 1465–72

    Article  PubMed  CAS  Google Scholar 

  77. Whitehouse, Y (1976). Ambivalent role of copper in inflammatory disorders. Agents and Actions, 6, 201–6

    Article  PubMed  CAS  Google Scholar 

  78. Gerber, A (1974). Copper catalized thermal aggregation of human gamma globulin. Arthr Rheum, 17, 85–91

    Article  CAS  Google Scholar 

  79. Chung, MH, Kesner, L and Chan, PC (1984). Degradation of articular cartilage by copper and hydrogen peroxide. Agents and Actions, 15(3/4), 328–35

    Article  PubMed  CAS  Google Scholar 

  80. Blake, RD, Hall, ND, Bacon, PA et al. (1981). The importance of iron in rheumatoid disease. Lancet, 2, 1142–4

    Article  PubMed  CAS  Google Scholar 

  81. Sorenson, JRJ (1982). Copper complexes as the active metabolites of anti-inflammatory agents. In: Sorenson, JRJ (ed), Inflammatory Disease and Copper. (Clifton, NJ: Humana Press), pp. 289–301

    Google Scholar 

  82. Wilson, T, Katz, JM and Gray, DH (1981). Inhibition of active bone resorption by copper. Calcif Tissue Int, 33, 35–9

    Article  PubMed  CAS  Google Scholar 

  83. Katz, JM, Skinner, SJM, Wilson, T and Gray, DH (1984). Inhidbition of prostaglandin action and bone resorption by copper. Ann Rheum Dis, 43, 841–6

    Article  PubMed  CAS  Google Scholar 

  84. Bonta, IL (1969). Microvascular lesions as a target of anti-inflammatory and certain other drugs. Acta Physiol Pharmacol Neerl, 15, 188–222

    PubMed  CAS  Google Scholar 

  85. Lewis, AJ, Cattney, J, Teape, J et al. (1978). Copper and its involvement in the inflammatory process. Eur J Rjeumatol Inflamm, 1, 295–9

    CAS  Google Scholar 

  86. Bonta, IL, Bragt, PC and Muus, P (1982). Hepatic adaptation process during inflammatory conditions. Role of trace elements, lipid peroxidation and ceruloplasmin. In: Sorenson, JRJ (ed), Inflammatory Disease and Copper. (Clifton, NJ: Humana Press), pp. 243–53

    Google Scholar 

  87. Babier, BM, Kipnes, RS and Carnutte, A (1973). Biological defence mechanisms: the production by leukocytes of superoxide. J Clin Invest, 52, 741–4

    Article  Google Scholar 

  88. Bragt, PG, Schenkelaars, EPM and Bonta, IL (1979). Dissociation between prostaglandin and malonyldialdehyde formation in exudate and measured levels of malonyldialdehyde in plasma and liver during granulation inflammation in the rat. Prostaglandins Med, 2, 51–61

    Article  PubMed  CAS  Google Scholar 

  89. Cunnane, SC (1981). Zinc and copper interact antagonistically in the regulation of linolenic acid metabolism. Prog Lipid Res, 20, 601–3

    Article  PubMed  CAS  Google Scholar 

  90. Nugteren, DH, Beerthuis, RK and van Dorp, DA (1966). The enzymic conversion of all-cis-8,11,14-eicosatrienoic acid into prostaglandin E1 Rec Trav Chim, 85, 405

    Article  CAS  Google Scholar 

  91. Boyle, E, Freeman, PC, Goudie, AC et al. (1976). The role of copper preventing gastrointestinal damage by acidic anti-inflammatory drugs. J Pharm Pharmacol, 28, 865–8

    Article  CAS  Google Scholar 

  92. Williams, DA, Walz, DT and Foye, WO (1976). Synthesis and biological evaluation of Tetrakis (acetylsalicylate)-u-dicopper (II). J Pharm Sci, 65, 126–8

    Article  CAS  Google Scholar 

  93. Rainsford, KD and Whitehouse, MW (1976). Concerning the merits of copper aspirin as a potential anti-inflammatory drug. J Pharm Pharmacol, 28, 83–6

    Article  PubMed  CAS  Google Scholar 

  94. Lewis, AJ (1984). The role of copper in inflammatory disease. Agents and Actions, 15, 511–19

    Google Scholar 

  95. Lewis, AJ, Smith, WE and Brown, DH (1981). A comparison of the anti-inflammatory activities of copper complexes in different models of inflammation. In: Rainsford, KD et al (eds), Trace Elements in the Pathogenesis and Treatment of Inflammation. Agents and Actions Suppl. Vol.8. (Basel: Birkhauser Verlag), pp.

    Google Scholar 

  96. Langfelder, E and Elsever, EF (1978). Determination of the superoxide dismutating activity of D-penicillamine copper. Hopper Seylers Zeitschr. Physiol Chem, 359, 51–757

    Google Scholar 

  97. Munthe, E, Aaseth, J and Jellum, E (1986). Trace elements and rheumatoid arthritis (RA). Pathogenetic and therapeutic aspects. Acta Pharmacol Toxicol, 59, 365–73.

    Article  CAS  Google Scholar 

  98. Munthe, E, Koss, E and Jellum, E (1981). D-penicillamine-induced increase in intracellular glutathione correlating to clinical response in rheumatoid arthritis. J Rheumatol, 8, 14–19

    Google Scholar 

  99. Smith, WE, Brown, DH, Dunlop, J et al. (1980). The effect of therapeutic agents on serum copper levels and serum oxidase activities in the rat adjuvant model compared to analogous results from studies of rheumatoid arthritis in humans. In: Willoughby, DA and Giroud, JP (eds), Inflammation: Mechanisms and Treatment. (Lancaster: MTP Press), pp. 459–66

    Google Scholar 

  100. Cutolo, M, Rovida, S, Samanta, E and Accordo, S (1982). Effect of drugs on serum copper and its correlation with other humoral factors in rheumatoid arthritis. In: Willoughby, DA and Giroud, JP (eds), Inflammation: Mechanisms and Treatment. (Lancaster: MTP Press), pp. 451–6

    Google Scholar 

  101. Rainsford, KD (1982). Environmental metal ion perturbation especially as they affect copper status, are factors in the etiology of arthritic conditions: a hypothesis. In: Sorenson, JRJ (ed), Inflammatory Diseases and Copper. (Clifton, NJ: Humana Press), pp. 137–42

    Google Scholar 

  102. Klevay, LM (1982). An appraisal of current human copper nutriture. In: Sorenson, JRJ (ed), Inflammatory Diseases and Copper. (Clifton, NJ: Humana Press), pp. 123–36

    Google Scholar 

  103. Klevay, LM (1981), Relationship between serum, zinc and copper and risk factors associated with cardiovascular disease. Am J Clin Nutr, 34, 597–8

    Google Scholar 

  104. Cartwright, GW (1950). In: McElroy, WD and Glass, B (eds), Copper Metabolism. (Maryland: Johns Hopkins Press), p274

    Google Scholar 

  105. Cartwright, GE and Wintrobe, MM (1964). Copper metabolism in normal subjects. Am J Clin Nutr, 14, 224–32

    PubMed  CAS  Google Scholar 

  106. Klevay, LM, Reck, SJ and Barcome, DF (1979). Evidence of dietary copper and zinc deficiencies. J Am Med Assoc, 241, 1916–18

    Article  CAS  Google Scholar 

  107. Taper, LJ, Hinners, ML and Ritchey, SJ (1982). Effect of zinc intake on copper balance in adult females. Am J Clin Nutr, 33, 1077–82

    Google Scholar 

  108. Milne, DB, Schnakenberg, DD, Johnson, HL and Kühl, GL (1980). Trace mineral intake of enlisted military personnel. Preliminary observations. J Am Diet Assoc, 76, 41–5

    PubMed  CAS  Google Scholar 

  109. Ritzmann, SE, Coleman, SL and Levin, WC (1960). The effect of some mercaptanes upon a macrocryogelglobulin; modifications induced by cysteamine, penicillamine and penicillin. J Clin Invest, 39, 1320–9

    Article  PubMed  CAS  Google Scholar 

  110. Jaffe, LA (1962). Intra-articular dissociation of the rheumatoid factor. J Lab Clin Med, 60, 409–21

    PubMed  CAS  Google Scholar 

  111. Meacock, SCR, Swann, BD and Dawson, W (1981). The dynamics and possible role of metal complexes in inflammation. In: Rainsford, KD, Brune, K and Whitehouse, MW (eds), Trace Elements in Pathogenesis and Treatment of Inflammation. (Basel: Birkhauser Verlag), pp.

    Google Scholar 

  112. Lipsky, PE and Ziff, M (1978). The effect of D-penicillamine on mitogen-induced human lymphocyte proliferation: synergistic inhibition by D-penicillamine and copper salts. J Immunol, 120, 1006–13

    PubMed  CAS  Google Scholar 

  113. Goldberg, LS and Barnett, EV (1970). Essential cryoglobulinemia. Immunologic studies before and after penicillamine therapy. Arch Intern Med, 125, 145–50

    Article  PubMed  CAS  Google Scholar 

  114. Bluestone, R and Goldberg, LS (1973). Effect of D-penicillamine on serum immunoglobulins and rheumatoid factor. Ann Rheum Dis, 32, 50–2

    Article  PubMed  CAS  Google Scholar 

  115. Jaffe, IA (1963). Comparison of the effects of plasmapheresis and penicillamine on the level of circulating rheumatoid factor. Ann Rheum Dis, 22, 71–6

    Article  PubMed  CAS  Google Scholar 

  116. Jaffe, IA (1965). The effect of penicillamine on the laboratory parameters in rheumatoid arthritis. Arthr Rheum, 8, 1064–79

    Article  CAS  Google Scholar 

  117. Schumacher, K, Maerker-Alzer, G and Preuss, R (1975). Effect of D-penicillamine on lymphocyte function. Arzneim-Forsch, 25, 603–6

    CAS  Google Scholar 

  118. Tabin, MS and Altman, K (1964). Accelerated immune response induced by D-penicillamine. Proc Soc Exp Biol Med, 115, 225–8

    Google Scholar 

  119. Hubner, KF and Gengozian, N (1965). Depression of the primary immune response by D-1-penicillamine. Proc Soc Exp Biol Med, 118, 561–5

    Google Scholar 

  120. Schumacher, K, Maerker-Alzer, G and Schaaf, W (1975). Influence of D-penicillamine on the immune response of mice. Arzneim-Forsch, 25, 600–3

    CAS  Google Scholar 

  121. Liyanage, SP and Currey, HL (1972). Failure of oral D-penicillamine to modify adjuvant arthritis or immune response in the rat. Ann Rheum Dis, 31, 521

    Article  PubMed  CAS  Google Scholar 

  122. Jaffe, IA (1970). The treatment of rheumatoid arthritis and necrotizing vasculitis with penicillamine. Arthr Rheum, 13, 436–43

    Article  CAS  Google Scholar 

  123. Golding, JR, Andrews, FM, Camp, V et al (1973). Controlled trials of penicillamine in severe rheumatoid arthritis. Ann Rheum Dis, 32, 385–6

    Article  PubMed  CAS  Google Scholar 

  124. Deshmukh, K and Nimni, ME (1969). A defect in the intramolecular and intermolecular cross-linking of collagen caused by penicillamine. II. Functional groups involved in the interaction process. J Biol Chem, 244, 1787–95

    PubMed  CAS  Google Scholar 

  125. Tismann, G, Herbert, V, Go, LT and Brenner, L (1972). Inhibition by penicillamine of DNA and protein synthesis in human bone marrow. Proc Soc Exp Biol Med, 139, 355–63

    Google Scholar 

  126. Chwalinska-Sadowska, H and Baum, J (1976). The effect of D-penicillamine on polymorphonuclear leukocyte function. J Clin Invest, 58, 871–9

    Article  PubMed  CAS  Google Scholar 

  127. Aposhian, HV (1961). Biochemical and pharmacological properties of the metal-binding agent penicillamine. Fed Proc, 20, 185–8

    PubMed  Google Scholar 

  128. Whitehouse, MW, Field, L, Denke, CW and Ryall, R (1975). Is penicillamine a precursor drug? Scand J Rheumatol, 4 (Suppl. 8), 183

    Google Scholar 

  129. Walshe, JM (1956). Penicillamine, a new oral therapy for Wilson’s disease. Am J Med, 21, 187–93

    Article  Google Scholar 

  130. Friedman, M (1977). Chemical basis for pharmacological and therapeutic action of penicillamine. Proc R Soc Med, 70 (Suppl. 3), 50–60

    PubMed  CAS  Google Scholar 

  131. Lengfelder, E, Fuch, C, Yonner, M and Weser, U (1979). Functional aspects of the superoxide dismutative action of Cu-penicillamine. Biochem Biophys Acta, 567, 492–502

    PubMed  CAS  Google Scholar 

  132. Muijsers, AO, Van de Stadt, RJ, Henrichs, AM et al. (1984). D-penicillamine in patients with rheumatoid arthritis. Serum levels, pharmacokinetic aspects and correlations with clinical course and side effects. Arth Rheum, 27, 1362–9

    Article  CAS  Google Scholar 

  133. Merryman, P and Jaffe, IA (1978). Effects of penicillamine on the proliferative response of human lymphocytes. Proc Soc Exp Biol Med, 157, 155–791

    PubMed  CAS  Google Scholar 

  134. Amor, B, Avery, C and Degery, A (1980). Tiopronine. New antirheumatic drug in rheumatoid arthritis. Rev Rheum, 47, 157–62

    CAS  Google Scholar 

  135. Pasero, G, Pellegrini, P, Ciompi, ML et al. (1980). Tiopronine; new basic treatment of rheumatoid arthritis. Rev Rheum, 47, 163–8

    CAS  Google Scholar 

  136. Huskisson, EC, Jaffe, IA, Scott, J and Dieppe, PA (1980). 5-thiopyridoxine in rheumatoid arthritis: Clinical and experimental studies. Arthr Rheum, 23, 106–10

    Article  CAS  Google Scholar 

  137. Lipsky, PE (1981). Modulation of lymphocyte function by copper thiols. Agents and Actions, (Suppl.), 8, 85–102

    CAS  Google Scholar 

  138. Zvaifler, NJ (1979). Etiology and pathogenesis of rheumatoid arthritis. In: McCarty, DJ (ed), Arthritis and Allied Conditions, 9th ed. (Philadelphia: Lea and Febiger), pp.

    Google Scholar 

  139. Krane, SM (1979). Mechanisms of tissue destruction in rheumatoid arthritis. In: McCarty, DJ (ed), Arthritis and Allied Conditions, 9th ed. (Philadelphia: Lea and Febiger), pp.

    Google Scholar 

  140. Fernandez-Madrid, F (1985). Rheumatoid arthritis. In: Stone, J (ed), Dermatologic Immunology and Allergy. (St Louis: CV Mosby), pp. 425–55

    Google Scholar 

  141. Lipsky, P and Ziff, M (1982). The mechanism of action of gold and D-penicillamine in rheumatoid arthritis. In: Ziff, M et al (eds), Advances in Inflammation Research. (New York: Raven Press, Vol.3, pp. 219–35

    Google Scholar 

  142. Perrett, D, Sneddon, W and Stephens, AD (1976). Studies on D-penicillamine metabolism in cystinuria and rheumatoid arthritis: isolation of S-methylpenicillamine. Biochem Pharmacol, 25, 259–64

    Article  PubMed  CAS  Google Scholar 

  143. Dormandy, TL (1980). In: Biological Roles of Copper. Ciba Foundation Symposium. (Amsterdam: Excerpta Medica), Vol.2, p293

    Google Scholar 

  144. Osterberg, R (1980). Therapeutic uses of copper chelating agents. In: Biological Roles of Copper. Ciba Foundation Symposium. (Amsterdam: Excerpta Medica), p.283–299

    Google Scholar 

  145. Mery, C, Delrieu, F, Ghozlan, R et al. (1976). Controlled trial of D-penicillamine in rheumatoid arthritis. Scand J Rheumatol, 5, 241–7

    Article  PubMed  CAS  Google Scholar 

  146. Prasad, AS, Brewer, GJ, Schoolmaker, EB and Rabbani, P (1978). Hypocupremia induced by zinc therapy in adults. J Am Med Assoc, 240, 2166–8

    Article  CAS  Google Scholar 

  147. Fischer, PF, Giroux, A and L’Abbé, MR (1984). Effect of zinc supplementation on copper status in adult man. Am J Clin Nutr, 40, 743–6

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Gordon Scott Hall of Basic Sciences, Wayne State University School of Medicine, Detroit, MI, 48201, USA

    Felix Fernandez-Madrid

Authors
  1. Felix Fernandez-Madrid
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Institute of Pharmacology, University of Verona, Italy

    R. Milanino  & G. P. Velo  & 

  2. Department of Biomedical Sciences, McMaster University Faculty of Health Sciences, Hamilton, Ontario, Canada

    K. D. Rainsford

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Kluwer Academic Publishers

About this chapter

Cite this chapter

Fernandez-Madrid, F. (1989). Copper therapy of inflammatory disorders in man: special reference to rheumatoid arthritis. In: Milanino, R., Rainsford, K.D., Velo, G.P. (eds) Copper and Zinc in Inflammation. Inflammation and Drug Therapy Series, vol 4. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-2619-6_5

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-2619-6_5

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-7682-1

  • Online ISBN: 978-94-009-2619-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation